About ALNA

Allena Pharmaceuticals, Inc. is a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, ALLN-177, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALNA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQWS Invesco Russell 2000 Equal Weight ETF 20.2 M 2.02E+07 1,952 1952 0.03% 0.0003 6 K 6130
IWC iShares Microcap ETF 918.7 M 9.18709E+08 1,459 1459 0.03% 0.0003 270 K 269688
IWM iShares Russell 2000 ETF 41.6 B 4.15714E+10 2,023 2023 0.01% 0.0001 2.2 M 2187920
IWO iShares Russell 2000 Growth ETF 9.0 B 8.96451E+09 1,249 1249 0.01% 0.0001 950 K 950323
IWV iShares Russell 3000 ETF 9.7 B 9.65281E+09 2,990 2990 0.0% 0 62 K 62067
URTY ProShares UltraPro Russell2000 117.7 M 1.17738E+08 2,034 2034 0.0% 9.17366E-06 4 K 3680
UWM ProShares Ultra Russell2000 172.9 M 1.7292E+08 2,034 2034 0.0% 1.83585E-05 7 K 7057
WMCR Invesco Wilshire Micro-Cap ETF 21.7 M 2.17E+07 1,082 1082 0.07% 0.00065 14 K 14122

Wait, Before You Leave...